Trial Profile
A Double-blind, Randomized, Crossover Clinical Study to Assess the Efficacy of Qutenza for the Reduction of Site Pain Caused by Continuous Subcutaneous Infusion of Remodulin, in Pulmonary Arterial Hypertension Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Capsaicin (Primary)
- Indications Pain
- Focus Adverse reactions
- 18 Nov 2015 New trial record